Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 7 of 7 for “"β blocker"”.

  1. The electrophysiological and molecular effects of chronic beta-adrenoceptor antagonist therapy on human atrium

    … patients treated and not treated with a β-blocker as a result of altered expression of ion channel pore-forming and accessory subunits. Human atrial myocytes were isolated enzymatically from right atrial appendage tissue obtained from consenting patients, in sinus rhythm, undergoing cardiac …

    glasgow Repository record for The electrophysiological and molecular effects of chronic beta-adrenoceptor antagonist therapy on human atrium (opens in a new tab)

  2. Heart failure and chronic obstructive pulmonary disease: common partners, common problems

    … in patients with HF and COPD. Although overall β-blocker prescribing increased over time, the adjusted odds of β-blocker prescription in patients with COPD was low (odds ratio 0.30 [95% CI 0.28–0.32], p<0.001). Whether the gap between patients with and without COPD is improving was previously …

    glasgow Repository record for Heart failure and chronic obstructive pulmonary disease: common partners, common problems (opens in a new tab)

  3. Clinical characteristics, causes, adherence to heart failure treatment guidelines and mortality of patients with acute heart failure: the Groote Schuur Hospital experience

    … Most patients received renin-angiotensin system blockers and loop diuretics on discharge. There was a low rate of β-blocker, aldosterone antagonist and digoxin use. Rehospitalisation at 180 days occurred in 25.2%. In-hospital mortality was 8.4 % and the case fatality rate at six months was 26.1%. …

    cape-town Repository record for Clinical characteristics, causes, adherence to heart failure treatment guidelines and mortality of patients with acute heart failure: the Groote Schuur Hospital experience (opens in a new tab)

  4. Impact Of Time-Varying And Time-Invariant Measures Of Adherence To Secondary Prevention Therapies Post-Acute Myocardial Infarction: An Application Of Marginal Structural Models (MSMS)

    … comprised of 1,091 patients, and cohorts B (β-blocker therapy) and C (angiotensin converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB) therapy) included 1,021 and 1,025 patients, respectively. When accounting only for baseline covariates in a discrete-event time model the …

    mississippi Repository record for Impact Of Time-Varying And Time-Invariant Measures Of Adherence To Secondary Prevention Therapies Post-Acute Myocardial Infarction: An Application Of Marginal Structural Models (MSMS) (opens in a new tab)

  5. Sustained Adrenergic Signaling Promotes Cervical Cancer Progression

    … We evaluated the <em>in vivo</em> effects of a β-blocker, propranolol, and HPV E6/E7 siRNA. <em>In vitro</em>, ADRβ positive cervical cancer cells were treated with norepinephrine (NE) or isoproterenol (ISO) to examine intracellular responses. Invasion and anoikis assays were performed to …

    uthsc Repository record for Sustained Adrenergic Signaling Promotes Cervical Cancer Progression (opens in a new tab)

  6. The Morbidity & Mortality of Prevalent Heart Failure

    … uptitrate dosages of beta-adrenergic blockade (β-blockers), angiotensin-converting-enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) to the most tolerable levels in order to reach target dosages, as recommended by the Heart Failure Society of America (HFSA). Patients were …

    loma-linda Repository record for The Morbidity & Mortality of Prevalent Heart Failure (opens in a new tab)